Details of the Drug

General Information of Drug (ID: DMCD2J2)

Drug Name

TMCB

Synonyms

ab120289; compound 2c [PMID: 22115617]; CK2/ERK8-IN-1; CHEMBL1233807; SCHEMBL1759230; GTPL8140; DTXSID50677589; BCP27716; ABP000318; ZINC58638742; BS0265; BDBM50359846; AKOS024457742; HY-135906; CS-0116229; Q27076513; K66

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C11H9Br4N3O2
Canonical SMILES: CN(C)C1=NC2=C(N1CC(=O)O)C(=C(C(=C2Br)Br)Br)Br
InChI: 1S/C11H9Br4N3O2/c1-17(2)11-16-9-7(14)5(12)6(13)8(15)10(9)18(11)3-4(19)20/h3H2,1-2H3,(H,19,20)
InChIKey: PHAOTASRLQMKBE-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 46943415
CAS Number: 905105-89-7
TTD ID: D0A6QR

References

1	A SARS-CoV-2 protein interaction map reveals targets for drug repurposing